ID: ALA4162669
Chembl Id: CHEMBL4162669
PubChem CID: 145959217
Max Phase: Preclinical
Molecular Formula: C26H17Cl2N3O3
Molecular Weight: 490.35
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)Cn1c(Cc2ccc(Cl)cc2)nc2c(-c3ccc(Cl)cc3)nc3ccccc3c2c1=O
Standard InChI: InChI=1S/C26H17Cl2N3O3/c27-17-9-5-15(6-10-17)13-21-30-25-23(26(34)31(21)14-22(32)33)19-3-1-2-4-20(19)29-24(25)16-7-11-18(28)12-8-16/h1-12H,13-14H2,(H,32,33)
Standard InChI Key: SLYILAODMUJLCM-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 490.35 | Molecular Weight (Monoisotopic): 489.0647 | AlogP: 5.59 | #Rotatable Bonds: 5 |
| Polar Surface Area: 85.08 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
| #RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 3.81 | CX Basic pKa: 2.97 | CX LogP: 5.32 | CX LogD: 2.42 |
| Aromatic Rings: 5 | Heavy Atoms: 34 | QED Weighted: 0.32 | Np Likeness Score: -0.87 |
| 1. Crespo I, Giménez-Dejoz J, Porté S, Cousido-Siah A, Mitschler A, Podjarny A, Pratsinis H, Kletsas D, Parés X, Ruiz FX, Metwally K, Farrés J.. (2018) Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase., 152 [PMID:29705708] [10.1016/j.ejmech.2018.04.015] |
Source(1):
